|
|
|
41
|
4291AE
|
VANCOMYCIN 500MG INJ (CHC) (BQ)
|
VANCOMYCIN
|
VANCOMYCIN
|
500MG VIAL
|
BQ
|
4.24
|
4.2406
|
VIAL
|
56
|
VIAL
|
CHC
|
CARITAS HEALTHCARE PVT LTD
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
081228
|
ANTIBACTERIALS, MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTIBACTERIALS, MISCELLANEOUS
|
|
|
|
|
41
|
4291AK
|
VANCOMYCIN 500MG INJ (HET) (BQ)
|
VANCOMYCIN
|
VANCOMYCIN
|
10ML
|
BQ
|
4.08
|
4.0775
|
VIAL
|
56
|
VIAL
|
HET
|
HETERO DRUGS LTD
|
ALI
|
ALL HEALTH INC
|
|
08122816
|
GLYCOPEPTIDES
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
GLYCOPEPTIDES
|
|
|
|
|
42
|
4291AN
|
VANCOMAX 500MG INJ (JLP) VANCOMYCIN
|
VANCOMYCIN
|
VANCOMAX
|
20X500MG
|
BQ
|
49.47
|
2.47
|
VIAL
|
56
|
VIAL
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08122816
|
GLYCOPEPTIDES
|
2026-04-01
|
|
|
IV
|
0
|
GLYCOPEPTIDES
|
|
|
|
|
42
|
4291AP
|
VANCOMYCIN 500MG INJ (FSB)
|
VANCOMYCIN
|
VANCOMYCIN
|
500MG VIAL
|
BQ
|
3.34
|
3.34
|
VIAL
|
56
|
|
FSB
|
FLAGSHIP BIOTECH
|
STO
|
BRYDEN STOKES LTD
|
|
081228
|
ANTIBACTERIALS, MISCELLANEOUS
|
2026-04-01
|
|
Add to Contract
|
IV
|
0
|
ANTIBACTERIALS, MISCELLANEOUS
|
2026-03-05
|
|
|
|
40
|
4291Q
|
VANCOMYCIN 500MG INJ (GLN/AHI)
|
VANCOMYCIN
|
VANCOMYCIN
|
500MG VIAL
|
BQ
|
5.27
|
5.27
|
INJECTION
|
0
|
VIAL
|
GLN
|
GLAND
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08122816
|
GLYCOPEPTIDES
|
2022-04-01
|
2022-09-30
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
2022-03-29
|
|
|
|
40
|
4291V
|
VANCOMYCIN 500MG INJ (FSB/ATB)
|
VANCOMYCIN
|
VANCOMYCIN
|
500MG VIAL
|
BQ
|
4.08
|
4.08
|
INJECTION
|
0
|
VIAL
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08122816
|
GLYCOPEPTIDES
|
2022-04-01
|
2024-03-31
|
|
IV
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
4291V
|
VANCOMYCIN 500MG INJ (FSB) (BQ)
|
VANCOMYCIN
|
VANCOMYCIN
|
500MG VIAL
|
BQ
|
4.13
|
4.1319
|
VIAL
|
56
|
VIAL
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08122816
|
GLYCOPEPTIDES
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
GLYCOPEPTIDES
|
|
|
|
|
40
|
4291W
|
VAREDET 500MG INJ (ABB/PHA) VANCOMYCIN
|
VANCOMYCIN
|
VAREDET
|
10ML VIAL
|
C
|
7.99
|
7.99
|
INJECTION
|
0
|
VIAL
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
08122816
|
GLYCOPEPTIDES
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
4291W
|
VAREDET 500MG INJ (ABB/PHA) VANCOMYCIN (C)
|
VANCOMYCIN
|
VAREDET
|
10ML VIAL
|
C
|
7.99
|
7.99
|
INJECTION
|
|
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
8122816
|
GLYCOPEPTIDES
|
2022-04-01
|
2023-03-31
|
Delete from contract
|
IV
|
0
|
GLYCOPEPTIDES
|
2023-03-02
|
|
|
|
40
|
42931
|
VANCOMYCIN 1G INJ (KWA/ATB)
|
VANCOMYCIN
|
VANCOMYCIN
|
1G VIAL
|
BQ
|
20.39
|
20.39
|
INJECTION
|
0
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08122816
|
GLYCOPEPTIDES
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
2022-03-30
|
|
|
|
41
|
42931
|
VANCOMYCIN 1G INJ (KWA) (BQ)
|
VANCOMYCIN
|
VANCOMYCIN
|
1G VIAL
|
BQ
|
6.9
|
6.9045
|
VIAL
|
28
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08122816
|
GLYCOPEPTIDES
|
2024-04-01
|
2025-01-28
|
|
IV
|
0
|
GLYCOPEPTIDES
|
|
|
|
|
41
|
42931
|
VANCOMYCIN 1G INJ (KWA) (BQ)
|
VANCOMYCIN
|
VANCOMYCIN
|
1G VIAL
|
BQ
|
10.85
|
10.85
|
VIAL
|
28
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08122816
|
GLYCOPEPTIDES
|
2024-05-25
|
2026-03-31
|
|
IV
|
0
|
GLYCOPEPTIDES
|
2024-05-24
|
|
|
|
40
|
42934
|
VANCOMYCIN 1G INJ (MON/PHA)
|
VANCOMYCIN
|
VANCOMYCIN
|
1G VIAL
|
BQ
|
10.41
|
10.41
|
INJECTION
|
0
|
VIAL
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
08122816
|
GLYCOPEPTIDES
|
2022-04-01
|
2024-03-31
|
|
IV
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
42938
|
VANCOQURE 1G INJ (FSB/ATB) VANCOMYCIN
|
VANCOMYCIN
|
VANCOQURE
|
10ML
|
BQ
|
10.85
|
10.85
|
INJECTION
|
0
|
VIAL
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08122816
|
GLYCOPEPTIDES
|
2022-04-01
|
2024-03-31
|
|
IV
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
42
|
4293H
|
VANCOMAX 1G INJ (JLP) VANCOMYCIN
|
VANCOMYCIN
|
VANCOMAX
|
8X1G
|
BQ
|
41.45
|
5.18
|
VIAL
|
28
|
VIAL
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08122816
|
GLYCOPEPTIDES
|
2026-04-01
|
|
|
IV
|
0
|
GLYCOPEPTIDES
|
|
|
|
|
42
|
4293J
|
VANCOQURE 1G INJ (FSB) VANCOMYCIN
|
VANCOMYCIN
|
VANCOQURE
|
10ML
|
BQ
|
5.03
|
5.03
|
VIAL
|
28
|
|
FSB
|
FLAGSHIP BIOTECH
|
STO
|
BRYDEN STOKES LTD
|
|
08122816
|
GLYCOPEPTIDES
|
2026-04-01
|
|
Add to Contract
|
IV
|
0
|
GLYCOPEPTIDES
|
2026-03-09
|